For Research Use Only — Not for Human Consumption

GLP-1 (S)

Add Your Heading Text Here
Add Your Heading Text Here

Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist. In laboratory and in-vitro research environments, it is extensively utilized to study incretin pathways, glucose-dependent insulin secretion, gastric emptying rates, and broader metabolic homeostasis.

SKU: YPB.200

Sign in for pricing

Create a free researcher account to view pricing and order.

We Accept:

Certificate of Analysis (CoA)

Batch #23SEMA-1125 | HPLC & MS Analysis Verified

99.3%

Purity Score

< 0.1 %

Impurity Profile
Semaglutide (GLP-1) 10mg

product description

Semaglutide is a structurally modified analog of human glucagon-like peptide-1 (GLP-1). The peptide chain features a critical amino acid substitution at position 8 (alanine replaced by alpha-aminoisobutyric acid) to protect the compound from degradation by the dipeptidyl peptidase-4 (DPP-4) enzyme. Additionally, it contains a fatty acid diacid attached via a spacer, which promotes strong binding to serum albumin, thereby significantly extending its half-life for prolonged laboratory observation.

Current research models primarily focus on its mechanism of action regarding the stimulation of insulin secretion and the suppression of glucagon release. Furthermore, researchers utilize Semaglutide in animal models to investigate its interactions with central nervous system pathways, specifically targeting receptors in the hypothalamus that regulate appetite, caloric intake, and energy expenditure.

Molecular Profile
Molecular Formula
C187H291N45O59
Molecular Weight
4113.58 g/mol
Appearance
Lyophilized White Powder
CAS Number
910463-68-2
Storage Protocols
Storage Temp
-20°C (Long Term)
Light Protection
Light Sensitive (Amber Vial Required)
Solubility
Soluble in Bacteriostatic Water
Reconstitution Life
28-30 Days Refrigerated
Research Focus
Primary Mechanism
GLP-1 Receptor Agonism
Studied Alongside
Tirzepatide, Retatrutide, AOD-9604
Regulatory Status
Research Use Only

Clinical Bibliography

PubMed ID: 33567185

Once-Weekly Semaglutide in Adults with Overweight or Obesity.

The New England Journal of Medicine. (2021)
PubMed ID: 28899882

Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity.

Diabetes, Obesity and Metabolism. (2017)
PubMed ID: 28287515

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

The New England Journal of Medicine. (2016)
PubMed ID: 30122305

Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial.

The Lancet Diabetes & Endocrinology. (2019)

Commonly Researched With

2x Blend: CJC-1295 (No DAC) / Ipamorelin

From

Add Your Heading Text Here
Add Your Heading Text Here

Glutathione

From

Price range: $54.99 through $69.99

Add Your Heading Text Here
Add Your Heading Text Here

Sermorelin

From

Add Your Heading Text Here
Add Your Heading Text Here

Semax

From

Add Your Heading Text Here
Add Your Heading Text Here

Welcome to PureChain Peptides Research Community

To access our full list of Research Compounds, please create a free account below. As a verified member you will receive exclusive access to our full research catalog, purity updates, and technical briefings.
Simply enter your name and email to get started. A verification code will be sent to your email to unlock access.
For Research Use Only — Not for Human Consumption.

ATTENTION

This website contains research chemicals intended strictly for laboratory and research use only. You must be 18 years of age or older to enter. By clicking I AGREE you confirm that you are 18+ years of age, a qualified researcher, and understand these products are not for human consumption.